Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Syncona Ltd    BACT   GG00B8P59C08

SYNCONA LTD

(BACT)
  Report  
Real-time Quote. Real-time CHI-X - 09/19 11:30:00 am
238.5 GBp   +1.71%
06/27SYNCONA : Italian Bracco Imaging boosts portfolio with $450 million deal
RE
06/10SYNCONA LTD : annual earnings release
03/04Nightstar Therapeutics Shares Surge on Biogen Deal
DJ
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
09/13/2019 09/16/2019 09/17/2019 09/18/2019 09/19/2019 Date
245.5(c) 246(c) 240.5(c) 234.5(c) 238 Last
227 470 194 446 253 506 235 412 431 848 Volume
+1.45% +0.20% -2.24% -2.49% +1.49% Change
More quotes
Financials (GBP)
Sales 2020 30,0 M
EBIT 2020 -
Net income 2020 -
Debt 2020 -
Yield 2020 -
Sales 2021 -
EBIT 2021 -
Net income 2021 -
Debt 2021 -
Yield 2021 -
P/E ratio 2020 -
P/E ratio 2021 -
Capi. / Sales2020 51,9x
Capi. / Sales2021 -
Capitalization 1 556 M
More Financials
Company
Syncona Ltd is a closed-ended investment healthcare company which focuses on investing in and building global leaders in life science. The Company operates in two segments: life science portfolio and fund investments. The Company’s portfolio is made up of a small group of healthcare companies.... 
Sector
Closed End Funds
Calendar
11/20Earnings Release
More about the company
Latest news on SYNCONA LTD
06/27SYNCONA : Italian Bracco Imaging boosts portfolio with $450 million deal
RE
06/10SYNCONA LTD : annual earnings release
03/04Nightstar Therapeutics Shares Surge on Biogen Deal
DJ
03/04BIOGEN : Syncona to Make GBP254.6 Million on Nightstar Sale to Biogen
DJ
02/28SYNCONA : pours 21m into immuno-oncology company Anaveon
AQ
2018SYNCONA LTD : half-yearly earnings release
2018NIGHTSTAR THERAPEUTICS : Boost for UK biotech Nightstar after gene therapy treat..
AQ
2018SYNCONA : Blue Earth announces upcoming presentations at SNMMI
PU
2018SYNCONA : expands global leadership position in gene therapy with foundation of ..
PU
2018SYNCONA : Autolus announces appointment of Linda Bain to its Board of Directors
PU
More news
Analyst Recommendations on SYNCONA LTD
More recommendations
Sector news : Closed End Funds
09/13Yahoo Japan's Deal Aims to Lift Retail
DJ
09/12Yahoo Japan to Buy Stake in Fashion Site -- WSJ
DJ
09/11ELLIOTT TO AT&T : Be Like Verizon -- WSJ
DJ
09/06Altaba Declares $51.50/Share Distribution as Part of Liquidation
DJ
09/05Yahoo down for six hours, users vent out on Twitter
RE
More sector news : Closed End Funds
Chart SYNCONA LTD
Duration : Period :
Syncona Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYNCONA LTD
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 250,00  GBp
Last Close Price 234,50  GBp
Spread / Highest target 6,61%
Spread / Average Target 6,61%
Spread / Lowest Target 6,61%
EPS Revisions
Managers
NameTitle
Anne Prener Chief Executive Officer
Jeremy John Tigue Chairman
Thomas Alexander Gavin Henderson Non-Executive Director
Nicholas David Moss Senior Independent Director
Nigel John Keen Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SYNCONA LTD-12.34%1 943
ARES CAPITAL CORPORATION21.76%8 095
MACQUARIE KOREA INFRASTRUCTURE FUND--.--%3 372
FS KKR CAPITAL CORP10.04%2 956
GOLUB CAPITAL BDC INC13.64%2 483
TPG SPECIALTY LENDING INC15.04%1 379